Pfizer, Inc. vs Insulet Corporation — Stock Comparison
Q·Score Breakdown
6.5
Neutral
Overall
7.8
Bullish
Quality
Health
Growth
Valuation
Sentiment
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
PODD
Consensus analyst target of $326.35 is 86% above current price.
Analyst Consensus
HOLD
Target $29.00 (+10.2%)
27 analysts
BUY
Target $326.35 (+86.4%)
23 analysts
Fundamentals
PFE
PODD
19.4×
Trailing P/E
50.3×
9.4×
Forward P/E
21.7×
12.4%
Profit Margin
9.1%
75.8%
Gross Margin
71.6%
8.9%
ROE
18.1%
-1.2%
Revenue Growth
31.2%
—
Earnings Growth
3.9%
0.39
Beta
1.47
—
Price / Book
—
$149.8B
Market Cap
$12.1B
$22 – $29
52-Week Range
$158 – $355
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →